Skip to main content
. 2014 Oct 16;2014(10):CD005622. doi: 10.1002/14651858.CD005622.pub4

Wasiak 2011.

Methods Randomised, double‐blind, placebo‐controlled cross‐over study. Allocation concealment stated; method of randomisation stated; participants, staff and outcome assessors blind to treatment assignment and medication administration
Participants 45 participants with burns (mean % total body surface area 12.96%, range 3% to 55%) undergoing wound care procedures (i.e. dressing changes or debridement, or both) on 2 consecutive days following split skin‐graft surgery. Participants aged 16‐68 years
Interventions Intervention: lidocaine dose of 1.5 mg/kg/body weight followed by 2 boluses of 0.5 mg/kg at 5‐minute intervals followed by a continuous infusion
Control: 0.9% sodium chloride administered at an equivalent volume, dose and rate to that of lidocaine
Outcomes Verbal rating scale scores measured before, during and after the procedure; time to rescue analgesia; opioid requests and consumption using patient‐controlled analgesia; overall participant anxiety and level of satisfaction
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "subjects were randomized to one of two treatment sequence groups i.e. treatment A or treatment B, using block randomization"
Allocation concealment (selection bias) Low risk Quote: "Allocation of treatment regime was done using the opaque sealed envelope technique, in which envelopes with cards detailing which treatment regime were allocated to patients on the morning of each dressing"
Blinding (performance bias and detection bias) 
 All outcomes Low risk Quote: "Subjects, staff and researchers were blinded to treatment assignments with all study medications identical in appearance. During the infusion, research staff administering the study medication was blind to the outcome assessments and the patient and research assistant were blinded to the study medication administration"
Incomplete outcome data (attrition bias) 
 All outcomes Low risk The authors did not report any loss to follow‐up participants for the primary outcome measures
Selective reporting (reporting bias) Unclear risk Authors did not provide overall participant satisfaction and anxiety scores
Size High risk < 50 participants per treatment arm
Other bias Unclear risk Not stated